INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
145 hedge funds and large institutions have $1B invested in Insys Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 61 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
-1
Holders Change %
-0.68%
% of All Funds
4.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
24
Increased
61
Reduced
50
Closed
24
Calls
$32M
Puts
$73.8M
Net Calls
-$41.8M
Net Calls Change
-$13.2M
Top Buyers
| 1 |
O
OrbiMed
New York
|
$116M |
| 2 |
SCM
Scopia Capital Management
New York
|
$48.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$27.5M |
| 4 |
Wells Fargo
San Francisco,
California
|
$23.9M |
| 5 |
Goldman Sachs
New York
|
$20.3M |
